Australian Office REITs Stock News

Wesfarmers (ASX:WES) just announced a special dividend of A$0.40 per share along with a significant capital return of A$1.10 per security. Both are scheduled for early November. These payouts are drawing increased investor interest. See our latest analysis for Wesfarmers. Wesfarmers has served up more than just special payouts lately. After reaching year-to-date price gains of 13.09%, the share price has slipped in recent weeks, down 9.29% over the last month, highlighting shifting sentiment...

If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the share...

Key Insights Significant control over Generation Development Group by individual investors implies that the general...

Articore Group Limited ( ASX:ATG ) shareholders have had their patience rewarded with a 44% share price jump in the...

Readers hoping to buy TPG Telecom Limited ( ASX:TPG ) for its dividend will need to make their move shortly, as the...

Wagners Holding Company Limited ( ASX:WGN ) shares have continued their recent momentum with a 27% gain in the last...

Microba Life Sciences Limited's ( ASX:MAP ) price-to-sales (or "P/S") ratio of 2.7x may not look like an appealing...

Amid a week of subdued performance on the Australian market, with futures indicating a modest decline of around 0.5%, investors are navigating cautious sentiment influenced by global economic factors, including significant job cuts in the US and ongoing concerns over AI valuations. In such an environment, dividend stocks can offer a measure of stability and income potential, making them particularly appealing to those looking for reliable returns despite broader market uncertainties.

As the Australian market faces a potential dip of around 0.5% amid global economic concerns and a turbulent week, investors are keenly observing how local indices respond to external pressures like high US job cuts and fluctuating commodity prices. In such uncertain times, stocks with strong insider ownership can offer some reassurance, as they often indicate confidence from those closest to the company's operations and future prospects.

The Australian market is poised for a quiet end to the week, with futures indicating a slight decline of around 0.5%, following a turbulent period influenced by high job cuts in the US and ongoing concerns about AI valuations. Despite these broader market challenges, investors often seek opportunities in lesser-known areas like penny stocks, which can offer affordability and potential growth. Although the term "penny stocks" might seem outdated, it still holds significance as these smaller or...

Alliance Aviation Services Limited recently announced a sharp downgrade to its FY26 earnings outlook, citing higher aircraft purchase and maintenance costs, ongoing supply chain inflation, and an unresolved contract dispute, alongside the immediate resignation of founding Managing Director Scott McMillan and CFO Andrew Evans. The leadership transition, combined with rising cost pressures and internal reviews of business units and capital allocation, marks a pivotal period for the company's...

Artrya (ASX:AYA) is on investors’ radar this week, as anticipation grows ahead of its Q1 2026 earnings call scheduled for October 29, 2025. Market watchers are waiting to see how recent trends translate into results. See our latest analysis for Artrya. Momentum has been building for Artrya, with a 27.6% share price return over the past month and a remarkable 445.2% year-to-date. Over the last twelve months, total shareholder return stands at an impressive 576.0%, highlighting the surge in...

Santana Minerals Limited has been granted a 25-year mining permit for its Bendigo-Ophir Gold Project in Central Otago, New Zealand, allowing full extraction and processing rights at the Rise & Shine deposit and neighboring areas. This milestone secures a pivotal regulatory step, setting the stage for potential construction and first gold production pending environmental approvals expected by mid-2026. We’ll now explore how obtaining this critical permit may influence Santana Minerals’...

Those holding Genetic Signatures Limited ( ASX:GSS ) shares would be relieved that the share price has rebounded 26% in...

With a price-to-earnings (or "P/E") ratio of 13.5x Suncorp Group Limited ( ASX:SUN ) may be sending bullish signals at...

Investors who take an interest in AMA Group Limited ( ASX:AMA ) should definitely note that the Independent...

Investing can be hard but the potential fo an individual stock to pay off big time inspires us. Mistakes are...

Earlier this week, Neuren Pharmaceuticals announced record Q3 2025 DAYBUE™ sales of US$101.1 million and provided an updated royalty outlook as Acadia Pharmaceuticals narrowed its full-year U.S. net sales forecast for the Rett syndrome drug. This development highlights both strong demand for DAYBUE and the sensitivity of Neuren's earnings to royalty projections and its partnership with Acadia. We'll now examine how strong DAYBUE sales growth and the revised royalty outlook influence Neuren's...

IPH Limited recently announced that CEO Dr. Andrew Blattman will retire in the second half of 2026, prompting the company to begin a formal search for a new leader from both internal and external candidates. Dr. Blattman’s lengthy tenure saw IPH expand its footprint in Asia and enter the Canadian market, which has helped shape the group’s international presence and long-term direction. We'll examine how the planned CEO transition and leadership search may impact IPH's investment outlook and...

NRW Holdings' (ASX:NWH) stock is up by a considerable 39% over the past three months. However, we decided to pay...

Artrya Limited has announced its upcoming Q1 2026 earnings call, scheduled for October 29, 2025, signaling a key moment for stakeholders awaiting developments from the company. This earnings call has captured increased user attention, reflecting heightened anticipation in the absence of other major company announcements in recent weeks. We'll explore how anticipation around Artrya's upcoming earnings call shapes the company's investment narrative and investor expectations. Explore 27 top...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

With the business potentially at an important milestone, we thought we'd take a closer look at AML3D Limited's...

Nuix Limited ( ASX:NXL ) shares have had a horrible month, losing 33% after a relatively good period beforehand. For...